Attached files
file | filename |
---|---|
EX-23.1 - EX-23.1 - eFFECTOR Therapeutics, Inc. | ck0001828522-ex231_20.htm |
EX-5.1 - EX-5.1 - eFFECTOR Therapeutics, Inc. | ck0001828522-ex51_6.htm |
As filed with the Securities and Exchange Commission on January 7, 2021
Registration No. 333-
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM S-1
REGISTRATION STATEMENT
UNDER THE SECURITIES ACT OF 1933
LOCUST WALK ACQUISITION CORP.
(Exact name of registrant as specified in its charter)
Delaware |
|
6770 |
|
85-3306396 |
(State or other jurisdiction of |
|
(Primary Standard Industrial |
|
(I.R.S. Employer |
c/o Ledgewood PC
Two Commerce Square
2001 Market Street, Suite 3400
Philadelphia, PA 19103
(215) 731-9450
(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)
Chris Ehrlich
Chief Executive Officer
Locust Walk Acquisition Corp.
c/o Ledgewood PC
Two Commerce Square
2001 Market Street, Suite 3400
(415) 697-0763
(Name, address, including zip code, and telephone number, including area code, of agent for service)
Copies to:
Mark E. Rosenstein Derick Kauffman Two Commerce Square 2001 Market Street, Suite 3400 |
Douglas S. Ellenoff, Esq. Stuart Neuhauser, Esq. |
Approximate date of commencement of proposed sale to the public: As soon as practicable after the effective date of this registration statement.
If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933 check the following box. ☐
If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☒ 333-251496
If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐
If this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer |
|
☐ |
|
|
|
Accelerated filer |
|
☐ |
Non-accelerated filer |
|
☒ |
|
|
|
Smaller reporting company |
|
☒ |
|
|
|
|
|
|
Emerging Growth company |
|
☒ |
CALCULATION OF REGISTRATION FEE
Title of each class of securities to be registered |
|
Amount to be Registered |
|
Proposed maximum offering price per share(1) |
|
|
Proposed maximum aggregate offering price(1) |
|
|
Amount of registration fee |
|
|||
Units, each consisting of one share of Class A Common Stock, $.0001 par value, and one-third of one Warrant(2)(3) |
|
2,645,000 Units |
|
$ |
10.00 |
|
|
$ |
26,450,000 |
|
|
$ |
2,886 |
|
Shares of Class A Common Stock included as part of the Units(2)(3) |
|
2,645,000 Shares |
|
|
— |
|
|
|
— |
|
|
|
— |
(4) |
Warrants included as part of the Units(2)(3) |
|
881,667 Warrants |
|
|
— |
|
|
|
— |
|
|
|
— |
(4) |
Total |
|
|
|
|
|
|
|
$ |
|
|
|
$ |
2,886 |
(5) |
(1) |
Estimated solely for the purpose of calculating the registration fee. |
(2) |
Represents only the additional number of securities being registered. Does not include the securities that the Registrant previously registered on the Registration Statement on Form S-1 (File No. 333-251496). |
(3) |
Pursuant to Rule 416, there are also being registered an indeterminable number of additional securities as may be issued to prevent dilution resulting from stock splits, stock dividends or similar transactions. |
(4) |
No fee pursuant to Rule 457(g). |
(5) |
The Registrant previously registered securities having a proposed maximum aggregate offering price of $149,500,000 on its Registration Statement on Form S-1, as amended (File No. 333-251496), which was declared effective by the Securities and Exchange Commission on January 7, 2021. In accordance with Rule 462(b) under the Securities Act, an additional number of securities having a proposed maximum offering price of $26,450,000 is hereby registered, which includes securities issuable upon the exercise of the underwriters’ over-allotment option. |
The Registration Statement shall become effective upon filing with the Securities and Exchange Commission in accordance with Rule 462(b) under the Securities Act of 1933, as amended.
EXPLANATORY NOTE
This Registration Statement on Form S-1 is being filed with respect to the registration of 2,645,000 additional units of Locust Walk Acquisition Corp., a Delaware corporation (the “Registrant”), pursuant to Rule 462(b) under the Securities Act of 1933, as amended, and General Instruction V to Form S-1. Each unit consists of one share of Class A common stock and one-third of one warrant. Each whole warrant entitles the holder to purchase one whole share of Class A common stock at a price of $11.50 per share, subject to adjustments, and only whole warrants are exercisable. This Registration Statement relates to the Registrant’s Registration Statement on Form S-1, as amended (File No. 333-251496) (the “Prior Registration Statement”), initially filed by the Registrant on December 18, 2020 and declared effective by the Securities and Exchange Commission on January 7, 2021. The required opinion of counsel and related consent and the independent registered public accounting firm’s consent are attached hereto and filed herewith. Pursuant to Rule 462(b), the contents of the Prior Registration Statement, including the exhibits thereto, are incorporated by reference into this Registration Statement.
CERTIFICATION
The registrant hereby certifies to the Securities and Exchange Commission that (1) it has instructed its bank to pay the filing fee set forth on the cover page of this Registration Statement by a wire transfer of such amount to the Commission’s account at U.S. Bank as soon as practicable (but no later than the close of business as of January 8, 2021), (2) it will not revoke such instructions, (3) it has sufficient funds in the relevant account to cover the amount of such filing fee and (4) it will confirm receipt of such instructions by its bank during regular business hours no later than January 8, 2021.
PART II
INFORMATION NOT REQUIRED IN PROSPECTUS
Item 16. |
Exhibits and Financial Statement Schedules. |
(a) Exhibits. All exhibits filed with or incorporated by reference in the Registration Statement on Form S-1 (SEC File No. 333-251496) are incorporated by reference into, and shall be deemed a part of, this Registration Statement, and the following additional exhibits are filed herewith, as part of this Registration Statement:
Exhibit No. |
|
Description |
5.1 |
|
|
23.1 |
|
|
23.2 |
|
|
24.1 |
|
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, as amended, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Philadelphia, Commonwealth of Pennsylvania on this 7th day of January, 2021.
|
LOCUST WALK ACQUISITION CORP. |
|
|
|
|
|
By: |
/s/ Chris Ehrlich |
|
Name: |
Chris Ehrlich |
|
Title: |
Chief Executive Officer |
Pursuant to the requirements of the Securities Act of 1933, as amended, this registration statement has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
Name |
|
Position |
|
Date |
|
|
|
|
|
/s/ Chris Ehrlich |
|
Chief Executive Officer and Director |
|
January 7, 2021 |
Chris Ehrlich |
|
(Principal Executive Officer) |
|
|
|
|
|
|
|
* |
|
Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer) |
|
January 7, 2021 |
Daniel Geffken |
|
|
|
|
|
|
|
|
|
* By: |
/s/ Chris Ehrlich |
|
|
Chris Ehrlich, Attorney-in-fact |
|